By A Mystery Man Writer
New insights on the role of epigenetic alterations in hepatocellular c
Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity
MAT2A WT and Val11 expression in COS-1 cells treated with 10 mM 3MA (A)
Human MAT2A and MAT2B genetic polymorphisms observed during
Ekihiro SEKI, Professor, M.D., Ph.D., Cedars-Sinai Medical Center, Los Angeles, Department of Medicine
Mir-34: A New Weapon Against Cancer? - ScienceDirect
Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers - ScienceDirect
Keep a watchful eye on methionine adenosyltransferases, novel therapeutic opportunities for hepatobiliary and pancreatic tumours - ScienceDirect
Ainhoa IGLESIAS, Professor (Associate), Biochemistry, Universidad del País Vasco / Euskal Herriko Unibertsitatea, Leioa, UPV/EHU, Departamento de Genética, Antropología Física y Fisiología Animal
Epigenomes, Free Full-Text
Alternative mechanisms of miR-34a regulation in cancer
New insights on the role of epigenetic alterations in hepatocellular c
miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells, BMC Cancer
miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells, Cancer Cell International
Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells